a16z Capital Management as of June 30, 2026
Portfolio Holdings for a16z Capital Management
a16z Capital Management holds 19 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Space Exploration Techn Corp Class A Com Stk (SPCX) | 90.0 | $13B | 75M | 170.86 | |
| Navan Cl A (NAVN) | 4.5 | $645M | 28M | 22.87 | |
| Revolution Medicines (RVMD) | 1.2 | $173M | 921k | 187.28 | |
| Meta Platforms Cl A (META) | 0.8 | $120M | 213k | 563.29 | |
| Figma Class A Com Stk (FIG) | 0.8 | $108M | 6.0M | 18.09 | |
| Bioage Labs (BIOA) | 0.6 | $79M | 3.2M | 24.51 | |
| Block Cl A (XYZ) | 0.5 | $77M | 1.0M | 76.00 | |
| Erasca (ERAS) | 0.4 | $52M | 2.9M | 18.32 | |
| Maze Therapeatics (MAZE) | 0.4 | $51M | 1.7M | 29.84 | |
| Damora Therapeutics Com New (DMRA) | 0.2 | $32M | 1.2M | 26.01 | |
| Omada Health (OMDA) | 0.2 | $25M | 1.2M | 21.95 | |
| Nautilus Biotechnology (NAUT) | 0.1 | $17M | 9.1M | 1.87 | |
| Roblox Corp Cl A (RBLX) | 0.1 | $15M | 275k | 54.38 | |
| Aktis Oncology (AKTS) | 0.1 | $13M | 415k | 32.23 | |
| Camp4 Therapeutics Corp (CAMP) | 0.1 | $9.3M | 2.1M | 4.37 | |
| Bitgo Holdings Com Shs Cl A (BTGO) | 0.0 | $3.5M | 666k | 5.18 | |
| Kailera Therapeutics Common Stock | 0.0 | $3.1M | 140k | 22.03 | |
| Ginkgo Bioworks Holdings Cl A New (DNA) | 0.0 | $1.1M | 109k | 9.91 | |
| Ip Strategy Holdings (IPST) | 0.0 | $9.7k | 4.1k | 2.35 |
